Cargando…
Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
Breast cancer is the most common cancer in women worldwide and is a substantial public health problem. Screening for breast cancer mainly relies on mammography, which leads to false positives and missed diagnoses and is especially non-sensitive for patients with small tumors and dense breasts. The p...
Autores principales: | Yang, Ruozhu, Han, Yi, Yi, Wenjun, Long, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701846/ https://www.ncbi.nlm.nih.gov/pubmed/36451832 http://dx.doi.org/10.3389/fimmu.2022.1035402 |
Ejemplares similares
-
Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis
por: Mahmud, Shawn A., et al.
Publicado: (2019) -
Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer
por: Yang, Ruozhu, et al.
Publicado: (2023) -
Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19
por: Battaglini, Denise, et al.
Publicado: (2022) -
Autoantibodies as potential biomarkers for breast cancer
por: Zhong, Li, et al.
Publicado: (2008) -
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
por: Tesar, Vladimir, et al.
Publicado: (2021)